|
1
|
Ebahimzadeh K, Gholipour M, Samadian M, Taheri M, Ghafouri-Fard S. A Comprehensive Review on the Role of Genetic Factors in the Pathogenesis of Migraine. J Mol Neurosci 2021; 71:1987-2006. [PMID: 33447900 DOI: 10.1007/s12031-020-01788-1] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2020] [Accepted: 12/30/2020] [Indexed: 12/17/2022]
Abstract
Migraine is a common neurovascular condition. This disorder has a complex genetic background. Several single-nucleotide polymorphisms (SNPs) or mutations within genes regulating glutamatergic neurotransmission, cortical excitability, ion channels, and solute carriers have been associated with polygenic and monogenic forms of migraine. SNPs within ACE, DBH, TRPM8, COMT, GABRQ, CALCA, TRPV1, and other genes have been reported to affect the risk of migraine or the associated clinical parameters. The distribution of some HLA alleles within the HLA-DRB1, HLA-DR2, HLA-B, and HLA-C regions have also been found to differ between migraineurs and healthy subjects. In addition, certain mitochondrial DNA changes and polymorphisms in this region have been shown to increase the risk of migraine. A few functional studies have investigated the molecular mechanisms contributing to these genetic factors in the development of migraine. Here we review studies evaluating the role of genetic polymorphisms and mRNA/miRNA dysregulation in migraine.
Collapse
Affiliation(s)
- Kaveh Ebahimzadeh
- Skull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Mahdi Gholipour
- Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Mohammad Samadian
- Skull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Mohammad Taheri
- Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
| | - Soudeh Ghafouri-Fard
- Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
| |
Collapse
|
|
2
|
Bonuccelli A, Sciarrotta C, Esposito MG, Bianchi V, Miccoli M, Striano P, D’Angelo R, Valiani M, Randazzo E, Foiadelli T, Peroni D, Federico G, Orsini A. Peripheral Arterial Tonometry (EndoPAT)-measured Endothelial Dysfunction in Migraine with Aura children. ACTA BIO-MEDICA : ATENEI PARMENSIS 2021; 92:e2021345. [PMID: 35441605 PMCID: PMC9179064 DOI: 10.23750/abm.v92is4.12674] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/10/2021] [Accepted: 01/27/2022] [Indexed: 11/23/2022]
Abstract
BACKGROUND The association between Migraine with Aura (MA) and vascular disease has been previously reported. We investigated whether pre-clinical vascular alterations, such as Endothelial Dysfunction, are already present in children and adolescents with Migraine with Aura. METHODS We retrospectively enrolled 27 patients having Migraine with Aura, aged9 -18 years, and 31 age matched healthy control subjects to evaluateEndothelial Function by Peripheral Arterial Tonometry. This technique measures finger pulse wave amplitude, before and during reactive hyperaemia, and calculates the Augmentation Index (AI) and the Reactive Hyperaemia Index (RHI). We also set-up an Aura Severity Scale to assess disease severity and its relationship with AI and RHI alterations. RESULTS Also if the case-control study resulted only partially as significant, we found there is an inversely proportional relationship between the severity of the migraine measured with Aura Severity Scale and the values of the endoscore (a significantly reduced levels of AI (p-value <0,03) and a marginal reduction of RHI levels (p-value <0,07). CONCLUSION Further studies should explore the impact of pre-clinical vascular alterations in children and adolescents with Migraine with Aura.
Collapse
Affiliation(s)
- Alice Bonuccelli
- Pediatric Neurology, Pediatrie University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa
| | - Claudia Sciarrotta
- Pediatric Neurology, Pediatrie University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa
| | - Maria Grazia Esposito
- Pediatric Neurology, Pediatrie University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa
| | - Vanessa Bianchi
- Pediatric Diabetology, Pediatrie University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa, ‘
| | - Mario Miccoli
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
| | - Pasquale Striano
- Pediatric Neurology Unit, Dinogmi, Giannina Gaslini’s. Istitute, University of Genoa
| | - Riccardo D’Angelo
- Pediatric Neurology, Pediatrie University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa
| | - Margherita Valiani
- Pediatric Diabetology, Pediatrie University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa, ‘
| | - Emioli Randazzo
- Pediatric Diabetology, Pediatrie University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa, ‘
| | - Thomas Foiadelli
- Pediatric Clinic, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy
| | - Diego Peroni
- Pediatric Neurology, Pediatrie University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa,,Pediatric Diabetology, Pediatrie University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa, ‘
| | - Giovanni Federico
- Pediatric Diabetology, Pediatrie University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa, ‘
| | - Alessandro Orsini
- Pediatric Neurology, Pediatrie University Department, Azienda Ospedaliera Universitaria Pisana, University of Pisa
| |
Collapse
|
|
3
|
Liampas I, Siokas V, Mentis AA, Aloizou A, Dastamani M, Tsouris Z, Aslanidou P, Brotis A, Dardiotis E. Serum Homocysteine, Pyridoxine, Folate, and Vitamin B12 Levels in Migraine: Systematic Review and Meta‐Analysis. Headache 2020; 60:1508-1534. [DOI: 10.1111/head.13892] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2020] [Revised: 05/10/2020] [Accepted: 05/11/2020] [Indexed: 02/06/2023]
Affiliation(s)
- Ioannis Liampas
- Department of Neurology University Hospital of LarissaSchool of MedicineUniversity of Thessaly Larissa Greece
| | - Vasileios Siokas
- Department of Neurology University Hospital of LarissaSchool of MedicineUniversity of Thessaly Larissa Greece
| | - Alexios‐Fotios A. Mentis
- Department of Microbiology University Hospital of LarissaSchool of MedicineUniversity of Thessaly Larissa Greece
- Public Health Laboratories Hellenic Pasteur Institute Athens Greece
| | - Athina‐Maria Aloizou
- Department of Neurology University Hospital of LarissaSchool of MedicineUniversity of Thessaly Larissa Greece
| | - Metaxia Dastamani
- Department of Neurology University Hospital of LarissaSchool of MedicineUniversity of Thessaly Larissa Greece
| | - Zisis Tsouris
- Department of Neurology University Hospital of LarissaSchool of MedicineUniversity of Thessaly Larissa Greece
| | - Paraskevi Aslanidou
- Department of Neurology University Hospital of LarissaSchool of MedicineUniversity of Thessaly Larissa Greece
| | - Alexandros Brotis
- Department of Neurosurgery University Hospital of LarissaSchool of MedicineUniversity of Thessaly Larissa Greece
| | - Efthimios Dardiotis
- Department of Neurology University Hospital of LarissaSchool of MedicineUniversity of Thessaly Larissa Greece
| |
Collapse
|